{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:51:16Z","timestamp":1790697076577,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1124\/dmd.109.029199","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T00:48:38Z","timestamp":1254185318000},"page":"157-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Regulation of Gene Expression in Brain Tissues of Rats Repeatedly Treated by the Highly Abused Opioid Agonist, Oxycodone: Microarray Profiling and Gene Mapping Analysis"],"prefix":"10.1016","volume":"38","author":[{"given":"Hazem E.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insong J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hegang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Coop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie D.","family":"Eddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.109.029199_bib1","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1073\/pnas.142039099","article-title":"Cocaine sensitization and reward are under the influence of circadian genes and rhythm.","volume":"99","author":"Abarca","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.109.029199_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-328X(03)00057-3","article-title":"Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal.","volume":"112","author":"Ammon","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/dmd.109.029199_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/mol.104.005009","article-title":"Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance.","volume":"66","author":"Annereau","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib4","first-page":"PL47","article-title":"Increased brain P-glycoprotein in morphine tolerant rats.","volume":"66","author":"Aquilante","year":"2000","journal-title":"Life Sci"},{"key":"10.1124\/dmd.109.029199_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/03602538608998294","article-title":"Pharmacokinetics of mitoxantrone in man and laboratory animals.","volume":"17","author":"Batra","year":"1986","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.109.029199_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/mol.65.2.437","article-title":"Systemic morphine administration suppresses genes involved in antigen presentation.","volume":"65","author":"Beagles","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/1064-1297.12.3.163","article-title":"Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.","volume":"12","author":"Beardsley","year":"2004","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/dmd.109.029199_bib8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/dmd.106.009746","article-title":"In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics\/pharmacodynamics.","volume":"34","author":"Bostr\u00f6m","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.029199_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1440-1681.2007.04821.x","article-title":"Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.","volume":"35","author":"Chan","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/dmd.109.029199_bib10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpain.2005.05.004","article-title":"Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002\u20132004.","volume":"6","author":"Cicero","year":"2005","journal-title":"J Pain"},{"key":"10.1124\/dmd.109.029199_bib11","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/0008-5472.CAN-03-2033","article-title":"Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.","volume":"64","author":"Cisternino","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.109.029199_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jat\/27.2.57","article-title":"Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases.","volume":"27","author":"Cone","year":"2003","journal-title":"J Anal Toxicol"},{"key":"10.1124\/dmd.109.029199_bib13","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1021\/jm701457j","article-title":"Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs.","volume":"51","author":"Cunningham","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.109.029199_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2003.08.027","article-title":"Variable modulation of opioid brain uptake by P-glycoprotein in mice.","volume":"67","author":"Dagenais","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/mol.104.001701","article-title":"Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A.","volume":"67","author":"Ejendal","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00498250600861660","article-title":"Algorithms for network analysis in systems-ADME\/Tox using the MetaCore and MetaDrug platforms.","volume":"36","author":"Ekins","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.109.029199_bib17","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/jnr.20812","article-title":"Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal.","volume":"83","author":"Emeterio","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1124\/dmd.109.029199_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejps.2005.11.002","article-title":"The role of transporters in drug interactions.","volume":"27","author":"Endres","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.109.029199_bib19","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1124\/mol.106.026245","article-title":"The H+-linked monocarboxylate transporter (MCT1\/SLC16A1): a potential therapeutic target for high-risk neuroblastoma.","volume":"70","author":"Fang","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib20","series-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","author":"Gentleman","year":"2005"},{"key":"10.1124\/dmd.109.029199_bib21","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1523\/JNEUROSCI.09-12-04371.1989","article-title":"Identification of morphine- and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions of rat brain: regulation by acute and chronic morphine.","volume":"9","author":"Guitart","year":"1989","journal-title":"J Neurosci"},{"key":"10.1124\/dmd.109.029199_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2009.03.037","article-title":"Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions.","volume":"375","author":"Hassan","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.109.029199_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jps.21770","article-title":"Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation.","author":"Hassan","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.109.029199_bib24","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/jps.20893","article-title":"Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel\u2019s tissue distribution in Sprague Dawley rats.","volume":"96","author":"Hassan","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.109.029199_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v23n04_01","article-title":"A profile of OxyContin addiction.","volume":"23","author":"Hays","year":"2004","journal-title":"J Addict Dis"},{"key":"10.1124\/dmd.109.029199_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0009-9236(98)90051-0","article-title":"Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.","volume":"64","author":"Heiskanen","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.109.029199_bib27","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1124\/mol.104.003350","article-title":"The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA binding protein.","volume":"66","author":"Hempel","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pbb.2005.12.013","article-title":"Characterization of the antinociceptive effect of oxycodone in male and female rats.","volume":"83","author":"Holtman","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/dmd.109.029199_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00008877-200303000-00003","article-title":"The effects of FK506 on the development and expression of morphine tolerance and dependence in mice.","volume":"14","author":"Homayoun","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s11095-005-6154-y","article-title":"Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague-Dawley rats: influence of streptozotocin-induced diabetes.","volume":"22","author":"Huang","year":"2005","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.109.029199_bib31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.64.3.610","article-title":"Breast cancer resistance protein exports sulfated estrogens but not free estrogens.","volume":"64","author":"Imai","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jama.283.13.1710","article-title":"Trends in medical use and abuse of opioid analgesics.","volume":"283","author":"Joranson","year":"2000","journal-title":"JAMA"},{"key":"10.1124\/dmd.109.029199_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0773.1990.tb00838.x","article-title":"Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays.","volume":"67","author":"Kalso","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/dmd.109.029199_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0090-9556(24)11822-3","article-title":"Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.","volume":"27","author":"Letrent","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.029199_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0169-409X(02)00171-0","article-title":"Drug-drug interaction mediated by inhibition and induction of P-glycoprotein.","volume":"55","author":"Lin","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.109.029199_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/physiolgenomics.2001.6.3.169","article-title":"Gene expression following acute morphine administration.","volume":"6","author":"Loguinov","year":"2001","journal-title":"Physiol Genomics"},{"key":"10.1124\/dmd.109.029199_bib37","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1208\/aapsj070112","article-title":"Role of the breast cancer resistance protein (ABCG2) in drug transport.","volume":"7","author":"Mao","year":"2005","journal-title":"Aaps J"},{"key":"10.1124\/dmd.109.029199_bib38","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1523\/JNEUROSCI.0062-05.2005","article-title":"Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area.","volume":"25","author":"McClung","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/dmd.109.029199_bib39","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.bmcl.2006.12.042","article-title":"Opioids and efflux transporters. Part 1: P-glycoprotein substrate activity of N-substituted analogs of meperidine.","volume":"17","author":"Mercer","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.109.029199_bib40","first-page":"1554","article-title":"Correlative association between N-methyl-d-aspartate receptor-mediated expression of period genes in the suprachiasmatic nucleus and phase shifts in behavior with photic entrainment of clock in hamsters.","volume":"58","author":"Moriya","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib41","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1124\/mol.105.019240","article-title":"Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation.","volume":"69","author":"Nagar","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3565(24)38873-1","article-title":"Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat.","volume":"295","author":"Nielsen","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.109.029199_bib43","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0026-895X(24)09259-9","article-title":"Sensitized increase of period gene expression in the mouse caudate\/putamen caused by repeated injection of methamphetamine.","volume":"59","author":"Nikaido","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2007.01.021","article-title":"Involvement of \u03bc1-opioid receptor on oxycodone-induced antinociception in diabetic mice.","volume":"560","author":"Nozaki","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2105-4-26","article-title":"Statistical implications of pooling RNA samples for microarray experiments.","volume":"4","author":"Peng","year":"2003","journal-title":"BMC Bioinformatics"},{"key":"10.1124\/dmd.109.029199_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0773.1992.tb00441.x","article-title":"Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats.","volume":"70","author":"P\u00f6yhi\u00e4","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/dmd.109.029199_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2164-5-61","article-title":"Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations.","volume":"5","author":"Shippy","year":"2004","journal-title":"BMC Genomics"},{"key":"10.1124\/dmd.109.029199_bib48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1073\/pnas.0231020100","article-title":"Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes.","volume":"100","author":"Sinars","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.109.029199_bib49","first-page":"MS35","article-title":"Regulation of various genes in human leukocytes acutely exposed to morphine: expression microarray analysis.","volume":"11","author":"Stefano","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1124\/dmd.109.029199_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.63.1.65","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.","volume":"63","author":"Wang","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.109.029199_bib51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1198\/016214504000000683","article-title":"A model-based background adjustment for oligonucleotide expression arrays. J Am","volume":"99","author":"Wu","year":"2004","journal-title":"Stat Assoc"},{"key":"10.1124\/dmd.109.029199_bib52","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1124\/mol.65.5.1208","article-title":"Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.","volume":"65","author":"Zhang","year":"2004","journal-title":"Mol Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624022633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624022633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.109.029199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:47:01Z","timestamp":1739897221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624022633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0090955624022633"],"URL":"https:\/\/doi.org\/10.1124\/dmd.109.029199","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of Gene Expression in Brain Tissues of Rats Repeatedly Treated by the Highly Abused Opioid Agonist, Oxycodone: Microarray Profiling and Gene Mapping Analysis","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.109.029199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}